Skip to main content

Dexamethasone Release from Uniform Sized Nanoengineered Alginate Microspheres

Buy Article:

$105.00 plus tax (Refund Policy)

The main objective of this work is to develop a novel technology based on nanoengineered alginate microspheres made using the droplet generator technique for controlled delivery of an immunomodulating agent at the site of implantation. Uniform sized alginate microspheres have been prepared using a commercially available droplet generator. SEM and optical micrographs confirmed the structure and spherecity of the prepared alginate microspheres. Release studies, completed on uncoated alginate microspheres, did not provide the desired profile. Layer-by-Layer (LbL) self assembly technique was further implemented on the uncoated alginate microspheres using standard polyelectrolyte pair. SEM, zeta potential measurements and QCM measurements were used to confirm the nanofilm coating on the alginate microspheres. Release studies conducted on the uncoated dexamethasone alginate microspheres demonstrate a cumulative release of 78% of initially encapsulated dexamethasone as compared to one and two bilayer coated microspheres, which demonstrate a release of 40% and 32% respectively. Thus, the application of nanofilm coating helped in reducing the initial burst release, thereby providing a means to control the release of drug over a longer period of time.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics


Document Type: Research Article

Publication date: 2007-09-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more